Home > Insider Trading > Filing (0001181431-11-038523)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1389870	Omni Bio Pharmaceutical Inc.	OMBP	Biological Products, (No Disgnostic Substances) (2836)	208097969

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1120570	D James Crapo	5350 South Roslyn Suite 430 Greenwood Village CO 80111	Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-06-27	40,000	$0.00	340,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants (Right to Buy)	Acquisiton	2011-06-27	40,000	$0.00	40,000	$2.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
40,000	2011-06-27	2016-06-27	No	4	P	Direct

Footnotes

The reporting person purchased 40,000 Units from the issuer in a private placement transaction for $1.25 per Unit. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock.
Includes 300,000 restricted stock units that can only be settled in common stock of the issuer. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in three equal installments on March 1, 2012, March 1, 2013 and March 1, 2014.